Literature DB >> 15748602

Serological diagnosis of infectious mononucleosis by chemiluminescent immunoassay using capsid antigen p18 of Epstein-Barr virus.

Zhenru Feng1, Zhiyan Li, Baohuan Sui, Guobing Xu, Tiean Xia.   

Abstract

BACKGROUND: Infectious mononucleosis is the common clinical manifestation of primary Epstein-Barr virus (EBV) infection in young children. We evaluated a chemiluminescent immunoassay method for the determination of serum anti-viral capsid antigen IgM antibody and its clinical value in the diagnosis of infectious mononucleosis.
METHODS: Concentrations of the antibody in serum samples from 187 children measured by chemiluminescent immunoassay were compared with those measured by ELISA.
RESULTS: Assessment of technologic quality (methodology) in diagnostic tests demonstrated that sensitivity of CLIA was 0.64 U/ml and the functional sensitivity was <0.9 U/ml. The within-assay and the between-assay imprecisions of different concentrations were all <5%. Recoveries were all in 93-107%. The linear regression equation between expected values and measured values was y=0.0967+1.0093x, correlation coefficient was 0.9996 (p<0.0001). The ROC curve showed that the sensitivity and specificity of the CLIA both were >90%. The area under the curve was 0.992, which was significantly higher than that of ELISA (p<0.05).
CONCLUSION: The CLIA was the excellent method for EBV-VCA IgM measurement at present and can improve the clinical diagnosis of infectious mononucleosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15748602     DOI: 10.1016/j.cccn.2004.11.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Determination of theophylline concentration in serum by chemiluminescent immunoassay.

Authors:  Mei-xia Zhou; Cha-ying Guan; Guang Chen; Xin-you Xie; Sheng-hai Wu
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

2.  Prevention of assay interference in infectious-disease serology tests done on the liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

3.  Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-12-30

5.  Is there diagnostic value in detection of immunoglobulin g antibodies to the epstein-barr virus early antigen?

Authors:  Andrea Crowley; Jeff Connell; Kirsten Schaffer; William Hall; Jaythoon Hassan
Journal:  Biores Open Access       Date:  2012-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.